Entera Bio Ltd (ENTX)
2.64
+0.13
(+5.18%)
USD |
NASDAQ |
May 15, 14:33
Entera Bio Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 42.86% |
| September 30, 2022 | 25.00% |
| June 30, 2022 | 25.00% |
| March 31, 2022 | 20.59% |
| December 31, 2021 | 17.58% |
| September 30, 2021 | 53.57% |
| June 30, 2021 | 9.17% |
| March 31, 2021 | 53.50% |
| Date | Value |
|---|---|
| December 31, 2020 | 11.31% |
| September 30, 2020 | 38.00% |
| June 30, 2020 | 40.38% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | -5.88% |
| September 30, 2019 | 33.33% |
| June 30, 2019 | 16.22% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-5.88%
Minimum
Dec 2019
53.57%
Maximum
Sep 2021
25.38%
Average
25.00%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
| BiomX Inc | -- |
| Compugen Ltd | -- |
| Pluri Inc | -- |
| BioLine Rx Ltd | -- |
| Can Fite Biofarma Ltd | -- |